Filipino firm granted license to distribute lagundi syrup

MANILA, Philippines - The government has granted a lagundi syrup license to Filipino firm Azarias Pharmaceutical Laboratories Inc. (APLI) which for the first time will generate royalties that will be churned back for local drug research and development.

This licensing agreement will be the first license between a research and development (R&D) agency, the University of the Philippines, and a private firm, Azarias, under a new regime since the Technology Transfer Act (TTA) was ratified a year ago.

The TTA has just created a new investment source for drug development in the country, according to Dr. Jaime C. Montoya, Philipppine Council for Health Research and Development executive director.

"This will generate royalties for (drug) research and development for the future. Before when we used to handle this, royalties were going to the national treasury. But by virtue of the law, the royalty should go to the investigator and research institution where the investigator belongs," said Montoya in an interview during the PCHRD's 29th anniversary celebration.

Montoya said the drug development sector expects a substantially bigger fund for the coming years from the former P2 million to P3 million yearly royalty from drug licensing that used to entirely go to the national treasury.

"If you imagine that there are more technology adopters now than before, the royalty will be even more. Pascual was the first in lagundi, now we have 10 adoptors. Many more companies are working on a license. But the more players, the better, so that drug price will drop," he said.

The cough syrup market, still dominated by multinational firms, is a big market that has offered many Filipino firms an opportunity to venture in.

"The therapeutic effects of lagundi is indeed a testimony that the indigenous medicinal products developed in the Philippines can very well compete with the more established preparations coming from imported pharmaceutical companies," said Azarias Operations Head Joel C. Monje.

Even advertising directed at criticizing the herbal drug proves how successful the Filipino-developed lagundi product has become.

"I think its a good sign because that means the herbal industry share is increasing because the reason why they're now doing these commercial ads is their sales are being affected. It tells you lagundi has now taken up a sizable market, said Montoya.

PCHRD estimates that the entire herbal industry may now be taking up 10 to 15 percent of the total market.

The criticism against herbal drugs is definitely contestable considering the same approval process for all drug types.

"I think there's no question herbal drugs can cure and can treat because this is based on critical trials. The requirement being imposed on conventional and synthetic drugs is also being imposed on herbal drugs," he said.

After the success of lagundi, Montoya said the drug R&D sector is now about to launch two other herbal drugs which have just undergone clinical trials.

"Ulasimang bato is already up for licensing this year as soon as we complete the technology package. Some people have already expressed interest to get a license, he said.

"We're also preparing the license package for sambong for which we have a new indication. Before it was only for the treatment of uric acid stone in the kidney. Now we also have indication for high uric acid level in the blood."

Ulasimang bato is for the treatment of biliary cholic. Its competitor drug is Buscopan. Sambong for the cure of high uric acid level has Allopurinol generic drugs as competitor.

With these prospects, as a drug product generator, UP Manila has already established a licensing office to hasten facilitation of drug R&D commercialization.


Editor’s note:Yahoo Philippines encourages responsible comments that add dimension to the discussion. No bashing or hate speech, please. You can express your opinion without slamming others or making derogatory remarks.

  • Philippine economic growth slows to three-year low
    Philippine economic growth slows to three-year low

    Philippine economic growth in the first quarter slowed to a three-year low of 5.2 percent, well below forecasts, due to lethargic government spending and weak exports, officials said Thursday. "While growth in the private sector remains robust, the slower than programmed pace of public spending, particularly the decline in public construction, has slowed down the overall growth of the economy," Economic Planning Secretary Arsenio Balisacan told reporters. "Exports were the other source of the …

  • EM ASIA FX-Won near 2-month low on plunging yen, peso pares gains as growth weakens

    * S.Korea intervention spotted, won hits 7-year high vs yen * Philippine peso briefly weaker after Q1 growth disappoints (Adds text, updates prices) By Jongwoo Cheon SEOUL, May 28 (Reuters) - South Korea's ... …

  • Britain's tied visa rules fuel abuse of live-in maids, nannies

    By Katie Nguyen LONDON (Thomson Reuters Foundation) - When Susi, a single mother from the Philippines, left for a job in Qatar, she convinced herself it was a sacrifice worth making for her children at home. For more than a year, Susi's sacrifice involved waking before dawn and working past midnight, cooking, cleaning and looking after a Qatari family. Conditions deteriorated when Susi was brought to Britain by her boss. …

  • SE Asia Stocks - Philippines at four-month low after Q1 GDP miss

    BANGKOK, May 28 (Reuters) - Philippine shares hit a more than four-month low on Thursday after economic growth in the first quarter was slower than expected, while Thai stocks retreated after disappointing ... …

  • Philippine economic growth slows to 5.2 percent in 1Q

    Sluggish government spending slowed Philippine economic growth in the first quarter of this year, officials said Thursday. The country's gross domestic product grew by 5.2 percent in the first quarter, ... …

  • PSE to sell Makati and Ortigas offices
    PSE to sell Makati and Ortigas offices

    Set to move to a unified headquarters in Bonifacio Global City in 2016, the Philippine Stock Exchange (PSE) has issued plans to sell their offices in Makati and Ortigas. PSE President Hans Sicat issued that PSE means to sell the offices, but that they may also opt to rent them out instead. …

  • ‘Inland areas could be exposed to tsunami-like waves’
    ‘Inland areas could be exposed to tsunami-like waves’

    While strong earthquakes cause tsunamis in coastal areas, the Philippine Institute of Volcanology and Seismology (Phivolcs) warned that inland areas could also be exposed to tsunami-like waves, or seiche, if located near or around bodies of water. In a recent earthquake awareness seminar in Muntinlupa, Phivolcs supervising science research specialist Joan Salcedo explained that a seiche is a large wave similar to a tsunami, triggered by strong ground shaking from an earthquake or volcanic …

  • China gives ‘gentle reminder’ to Phl, warns small nations
    China gives ‘gentle reminder’ to Phl, warns small nations

    China gave the Philippines a “gentle reminder” last Tuesday that Beijing will not bully small countries but warned these nations not to make trouble willfully and endlessly. “Here is a gentle reminder to the Philippines: China will not bully small countries, meanwhile, small countries shall not make trouble willfully and endlessly. The Chinese Foreign Ministry also said that China would continue to build other civilian facilities on relevant maritime features in the disputed Spratly Islands …


Should Aquino be held accountable over the Mamasapano operations?

Poll Choice Options